Sort
82,697 grants matching “vaccine development”
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,558,621Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2022 · HD
Natural History of HPV Infection to Neoplasia
$1,558,435University Of California San Francisco · R37 · FY2005 · CA
Poxvirus Modulation of Immune Responses
$1,558,237Janice S Blum · Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2006 · AI
Immunological responses to pan-CoV vaccines
$1,558,161Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
$1,558,030Martin J Blaser · Rbhs-Robert Wood Johnson Medical School · U01 · FY2020 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,557,495Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$1,557,469Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2019 · AI
Functional Biology Of T Cells
$1,556,824Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
IL-2IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,556,553Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,556,553Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2015 · CA
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,556,340Vanderbilt University · U01 · FY2004 · AI
Develop, Optimize and Commercialize UltraMarathonRT: A new enzyme for unbiased transcriptomic and epitranscriptomic characterization of RNAs regardless of length or composition.
$1,555,946Li-Tao Guo · Rnaconnect Inc · R44 · FY2024 · GM
Vaccine and Treatment Evaluation Units (VTEU)
$1,555,829Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
Phase 1 Malaria Vaccine Trial - VTEU
$1,555,265Karen L. Kotloff · University Of Maryland Baltimore · N01 · FY2015 · AI
Nonhuman Primate Reagent Resource
$1,555,000Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2025 · AI
Nonhuman Primate Reagent Resource
$1,555,000Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2024 · AI
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$1,554,922Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2016 · TR
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection
$1,554,735John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2014 · AI
Characterization of a low mutation rate E. coli in extended fermentation
$1,554,424Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2016 · GM
Task C02: Production and Development of Filarial Research Reagents
$1,554,403Andrew Riddel · University Of Georgia · N01 · FY2018 · AI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)
$1,554,254Eva Harris · University Of California Berkeley · U01 · FY2022 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2016 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2012 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2014 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2015 · AI